A Phase II Study of Non-Small Cell Cancer of the Lung Utilizing Low-Dose Weekly Therapy of Taxotere and Carboplatin
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Dec 2013
At a glance
- Drugs Carboplatin (Primary) ; Docetaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 09 Mar 2010 Planned number of patients changed from 20 to 38 as reported by ClinicalTrials.gov.
- 14 Sep 2005 New trial record.